Subsidiary Guarantors - Condensed Consolidating Statement of Cash Flows (Details) (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 28, 2014	Jun. 29, 2013
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	$ (88,431)	$ (39,964)
Investing Activities
Capital expenditures	(5,245)	(4,467)
Supply center acquisition	0	(348)
Proceeds from sale of assets	7	47
(Payments) receipts on loans to affiliates	0	0
Net cash (used in) provided by investing activities	(5,238)	(4,768)
Financing Activities
Borrowings under ABL facilities	121,242	100,944
Payments under ABL facilities	(41,128)	(154,158)
(Repayments) borrowings from affiliates	0	0
Equity contribution from parent	0	742
Issuance of senior notes	0	106,000
Financing costs	0	(5,104)
Net cash provided by (used in) financing activities	80,114	48,424
Effect of exchange rate changes on cash and cash equivalents	(417)	(184)
Net increase (decrease) in cash and cash equivalents	(13,972)	3,508
Cash and cash equivalents at beginning of period	20,815	9,594
Cash and cash equivalents at end of period	6,843	13,102
Company
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	(76,034)	(15,934)
Investing Activities
Capital expenditures	4,528	4,149
Supply center acquisition		348
Proceeds from sale of assets	5	47
(Payments) receipts on loans to affiliates	0	(20,000)
Net cash (used in) provided by investing activities	(4,523)	(24,450)
Financing Activities
Borrowings under ABL facilities	94,700	69,891
Payments under ABL facilities	20,700	119,391
(Repayments) borrowings from affiliates	5,689	(10,271)
Equity contribution from parent		742
Issuance of senior notes		106,000
Financing costs		4,629
Net cash provided by (used in) financing activities	79,689	42,342
Effect of exchange rate changes on cash and cash equivalents	0	0
Net increase (decrease) in cash and cash equivalents	(868)	1,958
Cash and cash equivalents at beginning of period	7,566	7,320
Cash and cash equivalents at end of period	6,698	9,278
Co-Issuer
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	0	0
Investing Activities
Capital expenditures	0	0
Supply center acquisition		0
Proceeds from sale of assets	0	0
(Payments) receipts on loans to affiliates	0	0
Net cash (used in) provided by investing activities	0	0
Financing Activities
Borrowings under ABL facilities	0	0
Payments under ABL facilities	0	0
(Repayments) borrowings from affiliates	0	0
Equity contribution from parent		0
Issuance of senior notes		0
Financing costs		0
Net cash provided by (used in) financing activities	0	0
Effect of exchange rate changes on cash and cash equivalents	0	0
Net increase (decrease) in cash and cash equivalents	0	0
Cash and cash equivalents at beginning of period	0	0
Cash and cash equivalents at end of period	0	0
Subsidiary Guarantors
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	5,938	(10,261)
Investing Activities
Capital expenditures	249	10
Supply center acquisition		0
Proceeds from sale of assets	0	0
(Payments) receipts on loans to affiliates	(5,689)	10,271
Net cash (used in) provided by investing activities	(5,938)	10,261
Financing Activities
Borrowings under ABL facilities	0	0
Payments under ABL facilities	0	0
(Repayments) borrowings from affiliates	0	0
Equity contribution from parent		0
Issuance of senior notes		0
Financing costs		0
Net cash provided by (used in) financing activities	0	0
Effect of exchange rate changes on cash and cash equivalents	0	0
Net increase (decrease) in cash and cash equivalents	0	0
Cash and cash equivalents at beginning of period	0	0
Cash and cash equivalents at end of period	0	0
Non-Guarantor Subsidiaries
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	(18,335)	(13,769)
Investing Activities
Capital expenditures	468	308
Supply center acquisition		0
Proceeds from sale of assets	2	0
(Payments) receipts on loans to affiliates	0	0
Net cash (used in) provided by investing activities	(466)	(308)
Financing Activities
Borrowings under ABL facilities	26,542	31,053
Payments under ABL facilities	20,428	34,767
(Repayments) borrowings from affiliates	0	20,000
Equity contribution from parent		0
Issuance of senior notes		0
Financing costs		475
Net cash provided by (used in) financing activities	6,114	15,811
Effect of exchange rate changes on cash and cash equivalents	(417)	(184)
Net increase (decrease) in cash and cash equivalents	(13,104)	1,550
Cash and cash equivalents at beginning of period	13,249	2,274
Cash and cash equivalents at end of period	145	3,824
Reclassification/Eliminations
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	0	0
Investing Activities
Capital expenditures	0	0
Supply center acquisition		0
Proceeds from sale of assets	0	0
(Payments) receipts on loans to affiliates	5,689	9,729
Net cash (used in) provided by investing activities	5,689	9,729
Financing Activities
Borrowings under ABL facilities	0	0
Payments under ABL facilities	0	0
(Repayments) borrowings from affiliates	(5,689)	(9,729)
Equity contribution from parent		0
Issuance of senior notes		0
Financing costs		0
Net cash provided by (used in) financing activities	(5,689)	(9,729)
Effect of exchange rate changes on cash and cash equivalents	0	0
Net increase (decrease) in cash and cash equivalents	0	0
Cash and cash equivalents at beginning of period	0	0
Cash and cash equivalents at end of period	$ 0	$ 0